Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting

Karl Voelkerding, a clinician who has been evaluating next-generation sequencing technologies for use in diagnostics, is developing a sequencing-based genetic test for hypertrophic cardiomyopathy.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.